|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-11-7
|
|
pubmed:abstractText |
Cilostazol is clinically used as an inhibitor of platelet aggregation. Although several reports have demonstrated its anti-inflammatory effect, its effect on monocytes and their adhesive interaction to vascular endothelium remains unclear. We thus examined the potential role of cilostazol towards monocyte endothelial interaction under physiological flow conditions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1340-3478
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
213-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17938542-Cell Adhesion,
pubmed-meshheading:17938542-Cells, Cultured,
pubmed-meshheading:17938542-Cyclic AMP,
pubmed-meshheading:17938542-Endothelial Cells,
pubmed-meshheading:17938542-Endothelium, Vascular,
pubmed-meshheading:17938542-Fetal Blood,
pubmed-meshheading:17938542-Flow Cytometry,
pubmed-meshheading:17938542-Humans,
pubmed-meshheading:17938542-Immunoassay,
pubmed-meshheading:17938542-Integrins,
pubmed-meshheading:17938542-Leukocyte Rolling,
pubmed-meshheading:17938542-Monocytes,
pubmed-meshheading:17938542-Platelet Aggregation Inhibitors,
pubmed-meshheading:17938542-Tetrazoles,
pubmed-meshheading:17938542-Tumor Necrosis Factor-alpha,
pubmed-meshheading:17938542-Up-Regulation
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP.
|
|
pubmed:affiliation |
Life Science and Bioethics Research Center, Tokyo Medical and Dental University, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
